⬤ Loading…
Centrus Energy Corp.
…
$2.1B
Market Cap
62.2
P/E
12.74
PEG
128.2%
ROCE
16.8%
ROE
1.59
D/E
9.7%
OPM
10
α RS
🔍 LEU is showing a multi-screen setup because it matches 3 of 39 tracked screener presets, Sector RRG has Energy in the Leading quadrant with the trail still strengthening, and an ECS of 54.9 last quarter. The main caution: the Oneil Leaders preset's Backtest win rate is only 44.3%. Net: Mixed signal stack, not a recommendation. ? Conviction RRG ECS Backtest
Sources
Conviction 3/39 · Energy in Leading quadrant · ECS 54.9 · Backtest win rate 44.3%
⚖️ Compare 🔒 Generate Report 🔒 Research Packet 📚 Guides
🌏 Global Investor Returns
Currency-adjusted total returns for LEU including FX impact
🌏
Click 🌏 Returns tab to load data
📈 Price History
Ratio Health
— Excellent
— Good
— Average
— Poor
By Category
📊 Peer Medians
About

Centrus Energy Corp. supplies nuclear fuel components for the nuclear power industry in the United States, Japan, the Netherlands, and internationally. The company operates through two segments: Low-Enriched Uranium (LEU) and Technical Solutions. The LEU segment sells separative work units (SWU) components of LEU; natural uranium hexafluoride, uranium concentrates, and uranium conversion; and enriched uranium products to utilities that operate nuclear power plants. The Technical Solutions segment offers technical, manufacturing, engineering, and operations services to public and private sector customers. The company was formerly known as USEC Inc. and changed its name to Centrus Energy Corp. in September 2014. Centrus Energy Corp. was incorporated in 1998 and is headquartered in Bethesda, Maryland.

Key Ratios Snapshot
📈 Growth Pattern
📊 Quick Scorecard
Loading…
⭐ Superinvestors Holding LEU
View All Superinvestors →
Manager Shares Value % of Fund Period
Jim Simons Renaissance Technologies LLC 160.5K $27.9M 0.04% Mar 2026
Steve Cohen Point72 Asset Management 17.3K $3.0M 0.00% Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
🎙 Management Tone Confident Specific → Stable 4 quarters Full tone analysis in Intelligence →
📊 MIXED Centrus Energy Q1 2026: Revenue $76.7M, backlog $3.9B, raises FY revenue guidance to $450M-$500M.
Revenue & Profitability
Q1 2026 revenue was $76.7 million, up 5% year-over-year. Gross profit was $31.5 million (vs $32.9 million in Q1 2025). Operating income was $0.8 million. Net income was $10 million ($0.45 diluted EPS); adjusted net income was $23.5 million ($1.05 adjusted diluted EPS). On a trailing twelve-month basis, revenue was $452.3 million, net income $60.6 million, and adjusted net income $87.8 million.
Outlook
Management sees strong and increasing demand for LEU and HALEU driven by existing reactor fleets and new advanced reactors. Global conflicts and energy security concerns are accelerating government support for nuclear power. SWU prices are trending upward due to constricted supply and growing demand. Management noted that advanced reactor developers and hyperscalers are now committing to fuel procurements.
Growth Drivers
Key growth levers include the $3.9 billion backlog, expansion of centrifuge manufacturing to address $2.4 billion in LEU commitments, and the build-out of 12 metric tons of HALEU capacity. National security contracts and the DOE HALEU award provide additional growth. The company is also exploring a joint venture with Oklo for HALEU deconversion services.
Balance Sheet & CapEx
2026 CapEx guidance is $350 million-$500 million. In Q1, total capital spend was $45.2 million ($23.2 million CapEx, $22 million non-CapEx including $17 million in growth costs and $5 million in Palantir prepayments). The company launched a $560 million investment in its Oak Ridge centrifuge plant. Through the Palantir partnership, Centrus has identified approximately $300 million in potential cost savings.
Margins
Gross profit margin in Q1 2026 was approximately 41% ($31.5 million gross profit on $76.7 million revenue). LEU segment cost of sales decreased 17% due to lower SWU volume, while Technical Solutions cost of sales increased 42% due to the HALEU operations contract. Advanced technology costs of $17 million (non-capitalizable) impacted net income. Management expects ongoing growth expenses but no specific margin guidance was provided.
Key Risks
Revenue can vary significantly quarter-to-quarter due to contract timing. The company is in a procurement cycle with the U.S. government, limiting disclosure. Dependence on cleared workforce and training timelines could affect build-out pace. Forward-looking statements involve risks and uncertainties detailed in SEC filings. Management noted the need to source employees and clear them through security as a potential constraint.
Generated by AI · Q1 2026 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter
🔍
🔎 See cross-company document search → ?
📞 Earnings Call Transcripts (5)
Q2 2026 Q2 2026 2026-08-06
Q2 2026 saw robust revenue growth, record backlog, and strong demand across LEU, national security, and HALEU markets. Major milestones included new DOE funding, HALEU supply agreements, and progress on capacity expansion, with guidance reaffirmed and workforce targets raised.
Q1 2026 Q1 2026 2026-05-06
Q1 2026 saw strong operational progress, a $900M HALEU award, and raised revenue guidance to $450–$500M. Segment results showed higher technical solutions revenue and improved gross margin, with $1.9B in cash supporting expansion and strategic partnerships.
Q4 2025 Q4 2025 2026-02-11
2025 saw record revenue, strong backlog growth, and a $900M HALEU award, positioning for domestic uranium enrichment and national security. 2026 guidance is flat, with major investments in capacity and workforce, and a focus on de-risking supply and execution.
Q3 2025 Q3 2025 2025-11-06
Q3 2025 revenue rose 30% year-over-year to $74.9 million, with net income of $3.9 million and a $3.9 billion backlog. Major capital raises, new hiring, and strong market demand position the company for rapid expansion amid tight enrichment supply and rising SWU prices.
Q2 2025 Q2 2025 2025-08-06
Q2 2025 saw strong gross margins and robust cash reserves despite lower revenue, with significant progress in HALEU production and a growing backlog. The company is well-positioned for future growth, pending DOE funding decisions and continued industry momentum.
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Catalyst Timeline.

Every result, order win, insider trade, ECS update, earnings-call, and SEC announcement for this company — in one chronological lane.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

Financial Model
Projections are built from each company's audited annual financials (Income Statement, Balance Sheet, Cash Flow) over the last 5 fiscal years. Forward assumptions — revenue growth %, EBITDA margin, D&A (USD millions), interest expense, tax rate, and capex — are AI-generated using historical context and refreshed twice a year: after the December results season and after the September/Q4 results season.

DCF Valuation
Fair Value = Σ(FCFt / (1+WACC)t) + Terminal Value. Terminal Value uses the Gordon Growth Model: FCF5 × (1+g) / (WACC−g). Default WACC: 10% (US risk-free ~4.5%, equity risk premium ~5.5%). Default terminal growth: 3% (long-run US nominal GDP proxy).

CAGR Tracker
Expected 5-year CAGR = (DCF Fair Value / Current Price)1/5 − 1. Assumes fair value is reached in exactly 5 years — a mechanical estimate only.

Data Sources & Limitations
Financial statements sourced from public filings. Prices updated daily. Forward assumptions are AI-generated. All monetary values in USD millions. Non-US ADR companies may have currency conversion inaccuracies. Models are point-in-time and do not update intra-quarter or account for M&A, macro shocks, or extraordinary items.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.